Background: A significant proportion of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease (MVD), and they are at high risk for recurrent cardiac events. The aim of the present study was to analyze the impact of MVD on long-term cardiovascular mortality in STEMI patients treated with primary percutaneous coronary intervention (pPCI). Method: This study included 3,115 consecutive STEMI patients hospitalized in the Coronary Care Unit of the Clinical Centre of Serbia, between November 2005 and January 2012. Patients were divided in two groups: MVD and no MVD. MVD disease was defined as stenosis greater than 50% by visual assessment in more than one major coronary artery. Primary PCI was limited to the infarct-related artery (IRA). Cardiovascular mortality was defined as any death from cardiovascular reason (myocardial reinfarction, low-output heart failure, and sudden death). Patients presenting with cardiogenic shock were excluded. Patients were followed-up for 6 years after enrollment. Results: Among 3,115 analyzed patients, 1,352 (43.4%) patients had no MVD and 1,763 (56.6%) had MVD; among patients with MVD, 926 (52.6%) had two-vessel disease and 837 (47.4%) had three-vessel disease. Compared with patients with single-vessel disease, patients with MVD were older, had longer pain duration, and presented more often with heart failure; they were more likely to have previous coronary artery disease, diabetes, hypertension, and chronic kidney disease; post-procedural flow TIMI <3 was more frequently observed in patients with MVD than in patients with no MVD (5.9% vs. 3.1%, p <0.001). Patients with MVD had lower left ventricular ejection fraction than patients with single-vessel disease: 45% (interquartile range [IQR] 40¬-55%) vs. 50% (IQR 43-55%), p <0.001. Revascularization of non-IRA lesions was performed at index hospitalization in 1,075 (61%) patients, and in 602 (34.1%) patients revascularization was performed in the first few months after pPCI (median 1.5 months, IQR 1-2.5 months); coronary artery bypass grafting was performed in 291 (18.4%) patients and PCI (with stent implantation) in 1,368 (81.6%) patients. Six-year cardiovascular mortality was significantly higher in patients with MVD than in patients with single-vessel disease (10.4% vs. 4.6%, p <0.001). In multivariate Cox regression analysis, MVD remained an independent
INTRODuCTION
Primary percutaneous coronary intervention (pPCI) is the reperfusion of choice for the treatment of patients with ST-segment elevation myocardial infarction (STEMI).
Primary PCI improves survival compared with thrombolysis, mainly due to the large percentage of restoration of TIMI 3 flow through the infarct-related artery (IRA). [1] [2] [3] [4] Concomitant atherosclerosis in coronary vessels other than the IRA is observed in a significant number of STEMI patients. 1, 2, [4] [5] [6] [7] [8] [9] According to the current guidelines, the standard therapeutic approach in STEMI patients with multi-vessel coronary artery disease (MVD) is represented by pPCI of the IRA in acute settings, followed by the subsequent revascularization of other lesions during the same hospitalization or, rarely, within the first month following discharge. 8, 10 A small number of patients are treated conservatively (medically), unless recurrent ischemia occurs. 3 Many studies so far have shown worse outcomes for STEMI patients with MVD compared to STEMI patients with single-vessel coronary artery disease (SVD) in shortand medium-term follow-up, regardless of the reperfusion strategy. 1, 3, [4] [5] [6] In STEMI subjects with MVD who undergo interventional therapies with angioplasty, a worse reperfusion rate is also observed when compared with patients with SVD. 2, 4, 6 The mechanism through which MVD adversely affects the outcome of patients with STEMI is multifactorial and relatively poorly characterized. 1, 6 To our best knowledge, the longer term impact of MVD on patient outcomes for STEMI treated with contemporary pPCI has not been extensively investigated so far.
The aim of the present study is to analyze the impact of MVD on long-term cardiovascular mortality in STEMI patients treated with pPCI.
METHODS
The present study used data from the prospective Clini- Patients were followed-up for 6 years after enrollment.
Follow-up data were obtained by scheduled telephone interviews and out-patient visits. Cardiovascular death included any death due to cardiac cause (myocardial reinfarction, low-output heart failure, fatal arrhythmia) and sudden death.
StatiStical analySiS
Continuous variables were expressed as the median 
RESuLTS
The average age of all analyzed patients was 59 (52-69) Figure 1 .
After adjustment for variables defined in univariate analysis as predictors of cardiovascular mortality, MVD remained an independent predictor of cardiovascular mortality during the 6-year follow-up.
DISCuSSIONS
The results of the present study confirmed that STEMI patients with MVD had higher long-term mortality compared to STEMI patients with no MVD. After multivariate 
CONCLuSIONS
In STEMI patients treated with pPCI, the presence of MVD is an independent predictor for higher long-term cardiovascular mortality, despite early revascularization of the remaining stenosis in non-IRA.
